ACTIVE

PHARMUNY

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

121 k €

+43.7% YoY

Gross margin

416,4 k €

+20.3% YoY

Equity

309,1 k €

+19.8% YoY

Workforce

2,4 ETP

+14.3% YoY

What does PHARMUNY do?

PHARMUNY is a Public limited company incorporated in 1991. Its registered office is in Ellezelles. It employs on average 2,4 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0443.874.077

Incorporation

05/04/1991

Legal form

Public limited company

Registered office

Place 16
7890 Ellezelles · WallonieSee on map

Contributed capital

61 500,00 €

Latest accounts

31/12/2025

Average workforce

2,4 ETP

Joint committees (1)

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 20 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007		2006
Income statement
Gross margin	416,4 k €	+20.3%	346,2 k €	-8.4%	378,1 k €	+12.7%	335,6 k €	+18.7%	282,7 k €	+3.1%	274,3 k €	-5.6%	290,7 k €	+8.6%	267,6 k €	+77.7%	150,6 k €	-63.4%	411,8 k €	+21.8%	338,1 k €	+2.1%	331,2 k €	+3.8%	319 k €	+27.3%	250,6 k €	-3.9%	260,7 k €	+7.0%	243,6 k €	+4.0%	234,3 k €	+4.0%	225,2 k €	+12.3%	200,5 k €	-1.3%	203,1 k €
EBITDA	240,2 k €	+22.9%	195,5 k €	-3.8%	203,3 k €	-3.2%	209,9 k €	+1.3%	207,2 k €	+1.2%	204,8 k €	-15.8%	243,1 k €	+7.9%	225,3 k €	+97.1%	114,3 k €	-60.5%	289,2 k €	+28.6%	224,9 k €	+4.3%	215,5 k €	+9.3%	197,1 k €	+35.7%	145,2 k €	-9.3%	160,1 k €	-6.8%	171,8 k €	+5.8%	162,4 k €	-1.3%	164,6 k €	+18.5%	138,9 k €	-1.2%	140,6 k €
Operating result	176,2 k €	+38.7%	127 k €	-5.0%	133,7 k €	-2.7%	137,4 k €	+9.7%	125,2 k €	+10.9%	112,9 k €	-16.8%	135,8 k €	+33.1%	102 k €	+651%	-18,5 k €	-112%	156,6 k €	+2.8%	152,3 k €	+0.7%	151,3 k €	+10.2%	137,3 k €	+41.6%	96,9 k €	-15.2%	114,3 k €	-19.8%	142,6 k €	+27.2%	112,2 k €	+53.1%	73,3 k €	-32.3%	108,2 k €	-6.2%	115,3 k €
Net result	121 k €	+43.7%	84,2 k €	-5.3%	89 k €	-4.6%	93,3 k €	+38.7%	67,2 k €	-2.1%	68,7 k €	-16.7%	82,5 k €	+5.7%	78 k €	+287%	-41,7 k €	-145%	92,3 k €	+1.0%	91,3 k €	+5.1%	86,9 k €	-1.5%	88,2 k €	+41.7%	62,3 k €	-12.0%	70,7 k €	-19.3%	87,6 k €	+52.0%	57,6 k €	+4.2%	55,3 k €	-29.8%	78,8 k €	-7.5%	85,2 k €
Balance sheet
Equity	309,1 k €	+19.8%	258,1 k €	+5.8%	243,8 k €	+8.4%	224,8 k €	+11.5%	201,6 k €	+9.3%	184,3 k €	-0.7%	185,7 k €	+79.9%	103,2 k €	+310%	25,2 k €	-95.2%	526,7 k €	+21.2%	434,4 k €	+19.6%	363,1 k €	+31.5%	276,2 k €	-0.7%	278,2 k €	+26.5%	219,9 k €	-47.1%	415,9 k €	+25.2%	332,3 k €	+19.3%	278,6 k €	+22.6%	227,3 k €	+49.1%	152,5 k €
Total assets	909,6 k €	-5.5%	962,8 k €	-4.0%	1 M €	-10.4%	1,1 M €	-2.5%	1,1 M €	-10.8%	1,3 M €	+4.5%	1,2 M €	-4.7%	1,3 M €	-11.0%	1,5 M €	-4.4%	1,5 M €	+84.4%	822,6 k €	+7.7%	764,2 k €	+2.5%	745,6 k €	+16.4%	640,7 k €	-19.1%	792 k €	+5.7%	749,2 k €	+10.6%	677,6 k €	-8.2%	738 k €	+103%	363,4 k €	+12.6%	322,8 k €
Cash	235,4 k €	-4.4%	246,4 k €	-4.3%	257,4 k €	-18.3%	315 k €	+18.2%	266,5 k €	-17.0%	321,1 k €	+83.4%	175,1 k €	+42.4%	123 k €	-32.4%	182 k €	-48.7%	354,8 k €	+175%	129,2 k €	+25.9%	102,6 k €	-22.7%	132,8 k €	+192%	45,4 k €	-67.8%	141,2 k €	-19.6%	175,6 k €	+83.0%	96 k €	-39.0%	157,3 k €	+120%	71,4 k €	+63.0%	43,8 k €
Debts	600,6 k €	-14.8%	704,7 k €	-7.1%	758,8 k €	-15.1%	894,3 k €	-5.5%	946,4 k €	-14.1%	1,1 M €	+5.4%	1 M €	-12.0%	1,2 M €	-16.7%	1,4 M €	+43.9%	990,6 k €	+155%	388,2 k €	-3.2%	401 k €	-14.6%	469,4 k €	+29.5%	362,5 k €	-36.6%	571,6 k €	+72.4%	331,6 k €	-3.0%	342 k €	-17.0%	411,9 k €	+219%	129,3 k €	-20.1%	161,9 k €
Other
Workforce	2,4 ETP	+14.3%	2,1 ETP	-30.0%	3,0 ETP	+25.0%	2,4 ETP	+118%	1,1 ETP	0.0%	1,1 ETP	+57.1%	0,7 ETP	+40.0%	0,5 ETP	-44.4%	0,9 ETP	-55.0%	2,0 ETP	0.0%	2,0 ETP	-4.8%	2,1 ETP	0.0%	2,1 ETP	0.0%	2,1 ETP	0.0%	2,1 ETP	+31.3%	1,6 ETP	0.0%	1,6 ETP	0.0%	1,6 ETP	+45.5%	1,1 ETP	-35.3%	1,7 ETP

Estimate

Indicative valuation

As an indication, this company is worth

between 500 k€ and 1 M€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 4 active · 16 ended

Active mandates

BENOIT DESCHAMPS

Director · since 01 juillet 2020 · until 01 juillet 2026

Active

Colette Delvigne

Director · since 01 juillet 2020 · until 01 juillet 2026

Active

PHARMUNY

Managing director · since 01 juillet 2020 · until 01 juillet 2026 · 0443.874.077

Represented by Hélène Deschamps

Active

SAMUEL VAN BAEL

Director · since 01 juillet 2020 · until 30 novembre 2025

Active

Ended mandates

BENOIT DESCHAMPS

Managing director · since 01 juillet 2020 · until 01 juillet 2026

Ended

PHARMUNY

Managing director · since 01 juillet 2020 · until 01 juillet 2020 · 0443.874.077

Represented by Hélène Deschamps

Ended

SAMUEL VAN BAEL

Director · since 01 juillet 2020 · until 01 juillet 2026

Ended

MEDILOG CONSULTING

Director · since 30 juin 2018 · until 30 juin 2024 · 0679.675.931

Represented by COLETTE DELVIGNE

Ended

At this address

Other companies at this address

Company	CBE no.
HCD Management● Active	0745.407.386
MEDILOG CONSULTING● Active	0679.675.931
MEDILOG GxP● Active	1011.137.797
VBS Consulting● Active	1032.079.307

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	22/06/2026	22/07/2025	26/07/2024	26/06/2023	01/07/2022	27/08/2021
General meeting	23/05/2026	24/05/2025	25/05/2024	27/05/2023	28/05/2022	22/05/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

20 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	23/05/2026	22/06/2026	French	PDF
Abridged model	31/12/2024	24/05/2025	22/07/2025	French	PDF
Abridged model	31/12/2023	25/05/2024	26/07/2024	French	PDF
Abridged model	31/12/2022	27/05/2023	26/06/2023	French	PDF
Abridged model	31/12/2021	28/05/2022	01/07/2022	French	PDF
Abridged model	31/12/2020	22/05/2021	27/08/2021	French	PDF
Abridged model	31/12/2019	23/05/2020	02/06/2020	French	PDF
Abridged model	31/12/2018	25/05/2019	24/06/2019	French	PDF
Abridged model	31/12/2017	26/05/2018	13/07/2018	French	PDF
Abridged model	31/12/2016	27/05/2017	27/07/2017	French	PDF
Abridged model	31/12/2015	28/05/2016	06/06/2016	French	PDF
Abridged model	31/12/2014	23/05/2015	30/06/2015	French	PDF
Abridged model	31/12/2013	24/05/2014	28/08/2014	French	PDF
Abridged model	31/12/2012	25/05/2013	31/05/2013	French	PDF
Abridged model	31/12/2011	24/02/2012	08/06/2012	French	PDF
Abridged model	31/12/2010	28/05/2011	20/07/2011	French	PDF
Abridged model	31/12/2009	22/05/2010	24/06/2010	French	PDF
Abridged model	31/12/2008	23/05/2009	19/06/2009	French	PDF
Abridged model	31/12/2007	24/05/2008	27/06/2008	French	PDF
Abridged model	31/12/2006	26/05/2007	20/08/2007	French	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 500 k€ and 1 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 4 active · 16 ended

Active mandates

BENOIT DESCHAMPS

Director · since 01 juillet 2020 · until 01 juillet 2026

Active

Colette Delvigne

Director · since 01 juillet 2020 · until 01 juillet 2026

Active

PHARMUNY

Managing director · since 01 juillet 2020 · until 01 juillet 2026 · 0443.874.077

Represented by Hélène Deschamps

Active

SAMUEL VAN BAEL

Director · since 01 juillet 2020 · until 30 novembre 2025

Active

Ended mandates

BENOIT DESCHAMPS

Managing director · since 01 juillet 2020 · until 01 juillet 2026

Ended

PHARMUNY

Managing director · since 01 juillet 2020 · until 01 juillet 2020 · 0443.874.077

Represented by Hélène Deschamps

Ended

SAMUEL VAN BAEL

Director · since 01 juillet 2020 · until 01 juillet 2026

Ended

MEDILOG CONSULTING

Director · since 30 juin 2018 · until 30 juin 2024 · 0679.675.931

Represented by COLETTE DELVIGNE

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates24/02/2026
DEMISSIONS, NOMINATIONS
PDF
Mandates23/12/2020
DEMISSIONS, NOMINATIONS
PDF
Mandates15/07/2019
DEMISSIONS, NOMINATIONS
PDF
Mandates24/07/2018
DEMISSIONS, NOMINATIONS
PDF
Restructuring23/08/2017
DENOMINATION - CAPITAL, ACTIONS - RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
PDF
Restructuring30/05/2017
RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
PDF
Mandates28/12/2016
DEMISSIONS, NOMINATIONS
PDF
Mandates19/09/2016
DEMISSIONS, NOMINATIONS
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 2025121 k €↑
2024
Annual accounts 202484,2 k €↓
2023
Annual accounts 202389 k €↓
2022
Annual accounts 202293,3 k €↑
2021
Annual accounts 202167,2 k €↓
2020
Annual accounts 202068,7 k €↓
2019
Annual accounts 201982,5 k €↑
2018
Annual accounts 201878 k €↑
2017
Annual accounts 2017-41,7 k €↓
2017
Name changePHARMUNY
2016
Annual accounts 201692,3 k €↑
2015
Annual accounts 201591,3 k €↑
2014
Annual accounts 201486,9 k €↓
2013
Annual accounts 201388,2 k €↑
2012
Annual accounts 201262,3 k €↓
2011
Annual accounts 201170,7 k €↓
2010
Annual accounts 201087,6 k €↑
2009
Annual accounts 200957,6 k €↑
2008
Annual accounts 200855,3 k €↓
2007
Annual accounts 200778,8 k €↓
2006
Annual accounts 200685,2 k €
2006
Name changeMEDILOG
05/04/1991
IncorporationPublic limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

PHARMUNY

Overview

What does PHARMUNY do?

Trend over 20 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline